Terms: = Kidney tumors AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Treatment
5 results:
1. KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer.
Qiu H; Makarov V; Bolzenius JK; Halstead A; Parker Y; Wang A; Iyer GV; Wise H; Kim D; Thayaparan V; Lindner DJ; Haber GP; Ting AH; Ren B; Chan TA; Arora V; Solit DB; Lee BH
Cancer Res; 2023 Mar; 83(6):814-829. PubMed ID: 36638328
[TBL] [Abstract] [Full Text] [Related]
2. Systematic Pan-Cancer Analysis and Experimental Verification Identify foxa1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.
Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
[TBL] [Abstract] [Full Text] [Related]
3. A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression.
Liu W; Ren D; Xiong W; Jin X; Zhu L
J Exp Clin Cancer Res; 2022 Jan; 41(1):38. PubMed ID: 35081978
[TBL] [Abstract] [Full Text] [Related]
4. Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects.
Osako T; Lee H; Turashvili G; Chiu D; McKinney S; Joosten SEP; Wilkinson D; Nielsen TO; Zwart W; Emerman JT; Eaves CJ; Caldas C; Aparicio S
Nat Cancer; 2020 May; 1(5):518-532. PubMed ID: 35121983
[TBL] [Abstract] [Full Text] [Related]
5. When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.
DeGraff DJ; Cates JM; Mauney JR; Clark PE; Matusik RJ; Adam RM
Urol Oncol; 2013 Aug; 31(6):802-11. PubMed ID: 21924649
[TBL] [Abstract] [Full Text] [Related]
